Mayence, Annie et al. published their research in Pharmaceuticals in 2019 |CAS: 321-28-8

The Article related to chloroquine primaquine tafenoquine antimalarial antiplasmodial agent malaria plasmodium, fda, plasmodium, aminoquinoline, approved drugs, hypnozoite, malaria, Placeholder for records without volume info and other aspects.Name: 1-Fluoro-2-methoxybenzene

Mayence, Annie; Eynde, Jean Jacques Vanden published an article in 2019, the title of the article was Tafenoquine: A 2018 Novel FDA-approved prodrug for the radical cure of Plasmodium vivax malaria and prophylaxis of malaria.Name: 1-Fluoro-2-methoxybenzene And the article contains the following content:

Tafenoquine (an 8-aminoquinoline) was approved by the Food and Drug Administration (FDA) in 2018 for the radical cure of Plasmodium vivax malaria and preventive action against malaria. Despite the fact that the mechanism of action of the drug remains unclear, all studies indicated that a metabolite is responsible for its efficacy. Routes for the preparation of the drug are described. The experimental process involved the reaction of 1-Fluoro-2-methoxybenzene(cas: 321-28-8).Name: 1-Fluoro-2-methoxybenzene

The Article related to chloroquine primaquine tafenoquine antimalarial antiplasmodial agent malaria plasmodium, fda, plasmodium, aminoquinoline, approved drugs, hypnozoite, malaria, Placeholder for records without volume info and other aspects.Name: 1-Fluoro-2-methoxybenzene

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem